10,11 Curcumin Preclinical and in vitro data suggest that curcumin can inhibit DPP-4 activity and enhance glycemic control in diabetic animal models, potentially prolonging the active life of GLP-1, although this has not been confirmed in human mechanistic studies
Retatrutide Explore a promising new weight loss medication currently undergoing clinical trials and what it could mean for future weight management
In 1990, a Canadian endocrinologist first isolated Exendin-4 from a Gila monsters saliva
Safety, Contraindications, and Medical Monitoring GLP-1 medications carry established contraindications: personal or family history of thyroid cancer, medullary thyroid carcinoma (MTC), multiple endocrine neoplasia type 2 (MEN2), pregnancy, pancreatitis risk, and severe kidney disease
Reflects longer-term use